7,587
Views
67
CrossRef citations to date
0
Altmetric
Original Articles

Antioxidative activity and health benefits of anthocyanin-rich fruit juice in healthy volunteers

, , , , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1045-1055 | Received 25 Feb 2019, Accepted 03 May 2019, Published online: 04 Jun 2019
 

Abstract

Oxidative cell damage has been linked to the pathogenesis of numerous diseases such as atherosclerosis, type 2 diabetes, and cancer. The consumption of foods rich in polyphenols (e.g. anthocyanins) has been shown to exert preventive effects against such diseases. We investigated the biological effects of anthocyanin-rich fruit juice in a 9-week, placebo-controlled intervention study with 57 healthy male volunteers. The study design encompassed an initial 1 week of wash-out, followed by 8 weeks of intervention period with anthocyanin-rich fruit juice or placebo. The anthocyanin-rich fruit juice demonstrated DNA-protective and antioxidant effects; however, the placebo beverage, rich in vitamin C, showed similar effects based on the tested biomarkers. A significant reduction in background and total DNA strand breaks was observed in both groups within 24 h as well as after 8 weeks of intervention. Only anthocyanin-rich fruit juice consumption provided a significant reduction in body fat and an increase in fat-free mass. The activity of superoxide dismutase (SOD) was significantly elevated after consumption of anthocyanin-rich fruit juice. Both groups showed decreased levels of LDL and total cholesterol (TC) within the first week of the intervention. Similar results in both groups could be explained by the relatively high vitamin C contents of both beverages (>500 mg/L), which may have masked the effects of anthocyanins and other antioxidants in the studied juice. Taken together, anthocyanin-rich fruit juice as well as the placebo drink, both of which had high vitamin C content, can improve DNA integrity and might influence lipid metabolism in humans.

Acknowledgements

The authors gratefully acknowledge the gift of FPG enzyme from Prof A.R. Collins (Institute for Nutrition Research, University of Oslo, Norway) and Dr. Dorothea Schipp for performing the randomisation of volunteers. The authors thank Dirk Galan and Karlos Kespohl for supporting the study. This research was supported by COST action no. CA 15132 (hCOST) Comet assay in human biomonitoring studies and COST Action CA16112 “Personalized nutrition in aging society: redox control of major age-related diseases (NutRedOx)”. The authors thank Dr. Teresa Röhrig, Laura Deitz, and Andreas Seegmüller for their support in compliance analysis.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

The presented study was supported by the German Ministry of Economics and Technology (via AiF) and the FEI (Forschungskreis der Ernährungsindustrie e.V., Bonn, Germany) cluster project no. 18068 N. JA Tur funded by CIBEROBN CB12/03/30038.